$620 Million is the total value of ORIX CORP's 1 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q1 2018 | ||||||||
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-05-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ORMAT TECHNOLOGIES INC | 24 | Q3 2023 | 100.0% |
View ORIX CORP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ORMAT TECHNOLOGIES, INC. | November 29, 2022 | 6,676,077 | 11.9% |
| Sucampo Pharmaceuticals, Inc.Sold out | June 18, 2015 | 0 | 0.0% |
View ORIX CORP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 6-K | 2024-06-05 |
| SD | 2024-05-30 |
| 6-K | 2024-05-28 |
| 13F-HR | 2024-05-14 |
| 6-K | 2024-05-08 |
| 6-K | 2024-03-06 |
| 13F-HR | 2024-02-13 |
| 6-K | 2024-02-13 |
| 6-K | 2024-02-07 |
| SC 13G/A | 2024-02-06 |
View ORIX CORP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Annual reports (20-F)
- Quarterly reports (6-K)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.